Nephrocare Health Services IPO
Nephrocare Health Services IPO is priced at ₹438–₹460 per share with an issue size of ₹871.05 crore. The IPO opens on Dec 17, 2025 and closes on Dec 19, 2025, with a lot size of 32 shares and a minimum investment of ₹14,720.
Nephrocare Health Services Limited IPO
- IPO Dates
- Dec 17, 2025 – Dec 19, 2025
- Price band
- ₹438-460 per equity share
- Minimum Investment
- ₹14,720
- Issue size
- ₹871.05 Cr
- Lot size
- 32
- Allotment Date
- Dec 15, 2025
- Listing
- Dec 17, 2025
- Listing At
- BSE, NSE
IPO timeline
-
Dec 17, 2025
Open Date
Completed
-
Dec 19, 2025
Close Date
Completed
-
Dec 15, 2025
Allotment Date
Completed
-
Dec 17, 2025
Listing Date
Completed
Nephrocare Health Services IPO Expected Premium (Grey Market Trend)
Nephrocare Health Services IPO GMP today is ₹10. Grey market premium (GMP) indicates expected listing sentiment.
Nephrocare Health Services IPO expected premium (also known as grey market premium or GMP) indicates current market sentiment and potential listing expectations.
Expected Premium provided in this website is derived from market rumors. It is not a guaranteed indicator of the actual listing price and should be interpreted with caution.
Nephrocare Health Services IPO Live Subscription Details
View Subscription DetailsNephrocare Health Services IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.
Last updated:Nephrocare Health Services IPO Essentials
Nephrocare Health Services IPO Details
Nephrocare Health Services IPO is priced at ₹438-460 per share with a total issue size of 871.05 crore. The IPO has a lot size of 32 shares and will be listed on BSE and NSE.
- Issue price
- ₹438-460 per equity share
- Lot size
- 32 shares
- Face value
- ₹2 Per Equity Share
- Issue size
- Total 871.05 Cr :
#Fresh Issue : 76,82,717 shares(aggregating up to ₹353.40 Cr) +
#OFS : 1,12,53,102 shares of ₹2(aggregating up to ₹517.64 Cr) - Total issue size
- 1,89,35,819 shares
(aggregating up to ₹871.05 crore) - Fresh issue
- 76,82,717 shares
(aggregating up to ₹353.4 crore) - Offer for sale (OFS)
- 1,12,53,102 shares
(aggregating up to ₹517.64 crore) - Listing at
- BSE, NSE
- Listing date
- Registrar
- Kfin Technologies Limited
- Lead manager
-
ICICI Securities Limited/nAmbit Pvt.Ltd, IIFL Capital Services Ltd., Nomura Financial Advisory & Securities (India) Pvt.Ltd.
Market Lot Size
Investors can bid for a minimum of 32 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 32 | ₹14,720 |
| Retail(max) | 13 | 416 | ₹1,91,360 |
| sHNI(min) | 14 | 448 | ₹2,06,080 |
| sHNI(max) | 67 | 2,144 | ₹9,86,240 |
| sHNI(min) | 68 | 2,176 | ₹10,00,960 |
Nephrocare Health Services IPO Reservation
Nephrocare Health Services IPO reservation details show category-wise allocation of shares. Out of the total 18935819 shares, approximately 19.9% are reserved for QIB, 14.93% for NII, 34.85% for retail investors, 0.44% for employees, and 29.88% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 5657919 (29.88%) | |
| QIB Shares Offered | 3768224 (19.9%) | |
| NII (HNI) Shares Offered | 2827843 (14.93%) | |
| bHNI > ₹10L | 1885229 (10%) | 4208 |
| sHNI < ₹10L | 942614 (5%) | 2104 |
| Retail Shares Offered | 6598301 (34.85%) | 206197 |
| Employee Shares Offered | 83532 (0.44%) | |
| Total Shares Offered | 18935819 (100%) |
Nephrocare Health Services IPO Analytics
Nephrocare Health Services IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Nephrocare Health Services IPO Subscription Status
Nephrocare Health Services IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO is currently subscribed 13.71x, indicating strong demand across investor categories.
| As on | QIB |
NII
bHNI
sHNI
|
Retail | Total |
|---|---|---|---|---|
| Day 1 - 10-12-25 05:00 PM | 0.00 x |
0.10x
0.07x
0.15x
|
0.21 x | 0.13 x |
|
Day 2
11-12-25 05:00 PM
|
0.29 x |
0.23x
0.16x
0.36x
|
0.47 x | 0.37 x |
|
Day 2
12-12-25 05:00 PM
|
0.30 x |
1.42x
1.61x
1.06x
|
0.83 x | 0.81 x |
|
Total No. of Applications
|
bHNI | sHNI | Retail |
|---|---|---|---|
| 358415 (Approx) | 6.11x | 11.77x | 1.47x |
Nephrocare Health Services Valuations
Returns
- ROE
- 13.45%
- ROCE
- 18.67%
- RoNW
- 13.19%
- PAT Margin
- 8.88%
Fundamentals
- Price / Book
- 7.72
- Market Cap
- 4615.34 Cr.
Nephrocare Health Services Financials( In Crs.)
| 30-Sep-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|---|
| Assets | 1193.68 | 996.46 | 806.02 | 666.23 |
| Revenue | 483.97 | 769.92 | 574.72 | 443.26 |
| Profit After Tax | 14.23 | 67.10 | 35.13 | -11.79 |
| Net Worth | 716.06 | 594.21 | 423.55 | 384.73 |
| Reserves & Surplus | 704.14 | 578.68 | 408.57 | 383.50 |
| Total Borrowing | 207.04 | 225.80 | 243.37 | 196.21 |
Nephrocare Health Services Company & Offer Insights
About Nephrocare Health Services
Nephrocare Health Services Ltd, incorporated in the year 2010, is an end-to-end dialysis care provider through its wide network of clinics across India and select international markets. It offers services such as diagnosis, haemodialysis, home and mobile dialysis, and wellness programs, supported by an in-house pharmacy.
As of March 31, 2025, Nephrocare operated 490 clinics—447 in India and 43 across the Philippines, Uzbekistan, and Nepal. This includes the world’s largest dialysis clinic in Uzbekistan. In India, the company had a presence across 269 cities in 21 States and four Union Territories. Approximately 76.73% of its clinics were located in tier II and tier III cities, addressing a critical need in underserved regions.
In Fiscal 2025, Nephrocare treated 29,281 patients and performed more than 2.88 million dialysis treatments, amounting to approximately 10% of the country's total dialysis patient base. The number of dialysis machines operated by the company increased to 5,068 as of March 2025 from 4,714 in Fiscal 2024 and 3,662 in Fiscal 2023.
Nephrocare has formulated strategic alliances with leading hospital chains like Max Super Speciality Hospital, Fortis Escorts Hospitals, Care Hospitals, Wockhardt Hospitals, Paras Healthcare, The Calcutta Medical Research Institute, Jehangir Hospital, and Ruby Hall Clinic to operate in-house dialysis centers.
As of March 2025, the workforce consisted of 3,230 employees, including both medical and administrative staff working across its clinics and corporate office.
Nephrocare Health Services Promoter(s)
Vikram Vuppala, Bessemer Venture Partners Trust, Edoras Investment Holdings Pte. Ltd, Healthcare Parent Limited, Investcorp Private Equity Fund II, Investcorp Growth Opportunity Fund are the company's promoters of Nephrocare Health Services.
Nephrocare Health Services IPO Issue Objectives
- •
- Capital expenditure by the Company for opening new dialysis clinics in India
- •
- Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by the Company
- •
- General corporate purposes
Nephrocare Health Services IPO - Anchor Investors
Nephrocare Health Services raises over Rs 260 crore from 14 anchor investors.
Nephrocare Health on Tuesday has finalised the allocation of 56.57 lakh shares to anchor investors at the upper price band. Of the total allocation, 25.82 lakh shares were allotted to 5 domestic mutual funds: SBI Mutual Fund, ICICI Prudential AMC, DSP MF, Baroda BNP Paribas MF and Bandhan MF.
Apart from these, Fidelity Funds, Prudential Assurance Company, Eastspring Investments, Polar Capital Funds, Manulife Global Fund, SBI Life Insurance Company, and HDFC Life Insurance Company also invested in the company via anchor book.
Nephrocare Health Services IPO - Strengths and Risks
Nephrocare Health Services IPO strengths and risks highlight key business factors, financial position, and market sentiment that may impact investor interest.
Strengths
Risks
Contact Information
Contact Details
Nephrocare Health Services
+91 40 4240 8039
5th Floor, D Block, iLabs Centre, Plot 18, Software Units Layout, Survey No. 64, Madhapur, Shaikpet, Hyderabad, Telangana, 500081
Registrar Contact Details
Kfin Technologies Limited
04067162222, 04079611000
Frequently Asked Questions
Click any question to reveal the answer
Nephrocare Health Services IPO is a book-built IPO worth ₹871.05 crore. The price band is ₹438–₹460 per share. The IPO opens on Dec 17, 2025 and closes on Dec 19, 2025. It will be listed on BSE and NSE. Kfin Technologies Limited is the registrar.
The price band of Nephrocare Health Services IPO is ₹438 to ₹460 per share.
The lot size of Nephrocare Health Services IPO is 32 shares.
The minimum investment for Nephrocare Health Services IPO is approximately ₹14,720 based on the upper price band .
Nephrocare Health Services IPO opens on Dec 17, 2025 and closes on Dec 19, 2025.
The allotment date of Nephrocare Health Services IPO is Dec 15, 2025.
Nephrocare Health Services IPO is expected to be listed on Dec 17, 2025, on BSE and NSE .
The Grey Market Premium (GMP) for Nephrocare Health Services IPO is ₹10-11 as of Dec 12, 2025. Based on the upper price band of ₹460, the estimated listing price is ₹470, representing a potential gain of approximately 2%.
Nephrocare Health Services IPO valuation snapshot: P/E N/A, EPS ₹/-, P/B 7.72, RoNW 13.19%, and market cap 4615.34 Cr.
To apply for Nephrocare Health Services IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Nephrocare Health Services IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Nephrocare Health Services IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Nephrocare Health Services IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Nephrocare Health Services IPO allotment status on IPO Ji for quick and easy access.